As a histone/protein deacetylase [51], SIRT1 promotes the viability, proliferation, invasion, stemness, and chemoresistance of PAAD [52], and high levels of SIRT1 are associated with a poor prognosis in patients with PAAD [53]. The gene discussed is SIRT1; the disease is pancreatic adenocarcinoma.